Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?

Arya, A. and Haghjoo, M. and Sadr-Ameli, M.A. (2005) Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease? Cardiovascular Drugs and Therapy, 19 (3). pp. 219-226.

[img]
Preview
Text
Cardiovascular Drugs and Therapy Volume 19 issue 3 2005 [doi 10.1007_s10557-005-2502-8] Arash Arya; Majid Haghjoo; Mohammad Ali Sadr-Ameli -- Can Amiodarone Prevent Sudden Cardiac Death in Patients .pdf

Download (352kB) | Preview
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

One of the most important challenges in today's cardiology is prevention of sudden cardiac death in high risk patients with coronary artery disease (CAD). Sustained hemodynamically tolerated ventricular tachycardia (HTVT) comprises up to 30 of all cases of monomorphic ventricular tachycardia in patients with CAD. While there is a consensus on treatment of hemodynamically unstable sustained ventricular tachycardia in patients with CAD, some controversies regarding the proper treatment of HTVT exist. We re-examined existing clinical evidence, controversies and current guidelines on the treatment of HTVT in patients with CAD and demonstrated that compared to implantable cardioverter-defibrillator, amiodarone is not an acceptable therapeutic option in patients with ischemic heart disease who suffer from HTVT. © 2005 Springer Science + Business Media, Inc.

Item Type: Article
Additional Information: cited By 1
Uncontrolled Keywords: amiodarone; antiarrhythmic agent; beta adrenergic receptor blocking agent; sotalol, cardiovascular risk; clinical protocol; clinical trial; comparative study; coronary artery disease; coronary hemodynamics; defibrillator; drug efficacy; drug indication; heart arrest; heart protection; heart ventricle tachycardia; high risk patient; human; ischemic heart disease; meta analysis; priority journal; prophylaxis; review; sudden death; survival rate; treatment outcome, Amiodarone; Clinical Trials; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Tachycardia, Ventricular
Subjects: WG Cardiovascular System
Depositing User: Librarian Farzaneh Dini
Date Deposited: 12 May 2019 09:35
Last Modified: 12 May 2019 09:35
URI: http://eprints.iums.ac.ir/id/eprint/12160

Actions (login required)

View Item View Item